Given that SLC25A39 was the only mitochondrial membrane transporter regulated by GSH depletion and its unknown function, we focused our attention on SLC25A39
Best case scenario is potentially 2026-2027 if trials succeed and FDA approval proceeds without delays
Rather than offering a long menu of peptides, we focus on options that make sense for real people and real goals
## Availability Status: March 2026 - **FDA status:** Phase 3 clinical trials ongoing - **Expected approval timeline:** Potentially 2026-2027 - **Brand availability:** None yet - **Current access:** Compounding pharmacies (503A/503B) with valid prescription For a detailed breakdown of [retatrutide's FDA approval status and projected timeline](/guides/retatrutide-fda-approval-2026-timeline-status), see our dedicated tracker the date brand pricing becomes available depends directly on when retatrutide clears FDA review
When to Seek Medical Attention According to prescribing information, patients should contact their healthcare provider immediately if experiencing: Severe abdominal pain that does not go away Signs of allergic reaction (swelling of face, lips, tongue, or throat
Optimizing hormone levels can improve metabolic functions, boost your energy levels, and support faster, more effective weight loss